Tuesday, 3 October 2023

Is this the ‘Unicorn Collapse’?

Plus, when a startup isn't a startup anymore

October 3, 2023

Hi, Agen. Twenty-three years ago, we had the Dot-Com Bubble. In 2008-2009, it was The Great Recession. But what do we call the current tech and startup market downturn? Perhaps one option is the “Unicorn Collapse,” posits Hans Swildens of Industry Ventures, an active investor during both prior downturns that’s now looking to acquire stakes in many of the heavily funded startups that have seen their valuations recede sharply.

💰 A secondary investor’s take on the current downturn

Industry Ventures is busier than ever, recently closing on a record $1.7 billion-plus across two new funds as it looks to buy up stakes of startups at discount prices. And these days, the cast of industry players looking to offload their stakes is quite wide — ranging from ​​corporate investors to pension funds.

See also: The Crunchbase Unicorn Board

💡 When is a startup not a startup anymore?

What do we mean when we call a company a startup? AI-focused investor Mikhail Taver of Taver Capital poses that question as he ponders whether a venture-backed company that’s established enough to buy other VC-backed companies is really a startup anymore and why those words matter anyway.

🏆 Top 10 deals: Anthropic and space tech lead the way

Nobody could beat OpenAI rival Anthropic when it came to the largest U.S. startup funding deals this week, but a few tried. They include a startup building a commercial space station, other AI companies, and, of course, a slew of biotech startups.

See also: The Crunchbase Megadeals Board

✂️ It’s not fun and games for these laid-off tech workers

The gaming sector was hardest-hit on our tech layoffs tracker last week, with nearly 900 workers in the industry losing their jobs.

🕺 Pivoting your startup? 5 strategies to get investors on board

Need to pivot your startup, but scared to talk to your investors about it? Entrepreneur Artem Semjanow, who’s navigated two successful pivots — from from B2C to B2B, and then from a sneakers company to an AI health app — shares five strategies to help you gain investor support when navigating pivots.

Recent Investments

Amicus Therapeutics

$400M / Post-IPO Debt

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

Categories:

Biotechnology • Health Care • Pharmaceutical • Therapeutics

Investors:

Blackstone Credit (Lead)

Canoo

$45M / Post-IPO Equity

Canoo is an electric vehicle startup company that focuses on developing electric vehicles and related technologies.

Categories:

Automotive • Consumer Electronics • Electric Vehicle • Electronic Design Automation (EDA)

Founders:

Andrew Wolstan, Phillip Weicker, Richard Kim, Stefan Krause, Ulrich Kranz

Adlai Nortye

$40M / Post-IPO Equity

Adlai Nortye is a clinical-stage biopharmaceutical company that deveops cancer treatments for diverse tumor types.

Categories:

Biotechnology • Health Care • Pharmaceutical

Founders:

Carsten Lu

Investors:

Nippon Kayaku

More Fundings

Company Amount / Round Lead Investor
Amicus Therapeutics $30M / Post-IPO Equity Blackstone Life Sciences
ReShape Lifesciences $3.0M / Post-IPO Equity -
Ginkgo Bioworks Unknown / Grant USDA Animal and Plant Health Inspection Service
Holmusk Unknown / Corporate Round Veradigm
All Recent Funding Activity

Recent Acquisitions

BudAB

Pending acquisition by Jetpak for 25M SEK

More Acquisitions

Company Acquired By Amount
Melchor Monadelphous Group $10M
All Recent Acquisition Activity

Discover innovative companies and the people behind them.

Follow Us on Crunchbase View Jobs on LinkedIn Follow Us on Twitter Like Us on Facebook

564 Market St, San Francisco, CA 94104
© 2023 Crunchbase Inc. All rights reserved. Privacy Policy | Terms of Service

Unsubscribe from Crunchbase Daily.

No comments:

Post a Comment